(R)-3-Amino-3-(6-methoxypyridin-3-yl)propanoic acid is primarily utilized in the pharmaceutical industry as a key intermediate in the synthesis of various therapeutic agents. Its chiral structure makes it valuable in the development of enantiomerically pure drugs, particularly those targeting neurological and psychiatric disorders. The compound is often employed in the production of selective inhibitors and modulators for receptors or enzymes involved in brain function. Additionally, it serves as a building block in organic synthesis for creating complex molecules with potential biological activity, contributing to advancements in medicinal chemistry and drug discovery.